Macro close-up of high-end scientific chromatography apparatus in a quiet, cool-toned laboratory, soft overcast daylight, sharp focus.
Macro close-up of high-end scientific chromatography apparatus in a quiet, cool-toned laboratory, soft overcast daylight, sharp focus.
Access Transition Directory
Scientific Archive

A legacy of oncology discovery

Documenting the clinical development and therapeutic milestones of our breakthrough small-molecule platform, now transitioned to global scale.

Therapeutic Platform

Targeting undruggable oncogenic pathways

Our proprietary platform successfully mapped and inhibited key intracellular signaling nodes, establishing a new benchmark for selective oncology therapeutics.

Quiet, empty modern laboratory bench with sterile scientific glassware under cool white light, architectural depth.
Quiet, empty modern laboratory bench with sterile scientific glassware under cool white light, architectural depth.
Abstract molecular structure visualization on a high-resolution dark monitor in a dimly lit research facility, sharp focus.
Abstract molecular structure visualization on a high-resolution dark monitor in a dimly lit research facility, sharp focus.
Clinical Milestones

A timeline of clinical precision

Phase I Trials

First-in-human safety profiles

Demonstrated exceptional tolerability and target engagement across diverse patient cohorts, validating our highly selective pathway inhibition mechanism in clinical settings.

Phase II Expansion

Robust efficacy signals

Achieved clinically meaningful tumor regression and prolonged progression-free survival in advanced refractory solid tumor populations during multi-center expansion studies.

A Final Note of Gratitude

We express our deepest gratitude to the patients, clinical investigators, and scientific partners who made this breakthrough possible.

The Aethel Oncology Scientific Advisory Board